We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBK icon
6026
PUT
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
$1.54M ﹤0.01%
7,900
-6,000
-43% -$1.29M
MRNS
6027
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.54M ﹤0.01%
231,828
+12,338
+6% +$76K
TMDX icon
6028
CALL
Transmedics
TMDX
$3.06B
$1.54M ﹤0.01%
36,900
+20,600
+126% +$896K
ARQT icon
6029
Arcutis Biotherapeutics
ARQT
$3.22B
$1.54M ﹤0.01%
80,515
-111,996
-58% -$2.54M
SAFT icon
6030
Safety Insurance
SAFT
$1.52B
$1.54M ﹤0.01%
18,852
+14,477
+331% +$1.31M
NVRO
6031
PUT
DELISTED
NEVRO CORP.
NVRO
$1.54M ﹤0.01%
33,000
+23,400
+244% +$1.09M
AJG icon
6032
Arthur J. Gallagher & Co
AJG
$63.6B
$1.54M ﹤0.01%
8,979
-254,255
-97% -$45.1M
THFF icon
6033
First Financial Corp
THFF
$970M
$1.54M ﹤0.01%
34,010
-15,400
-31% -$711K
IGV icon
6034
iShares Expanded Tech-Software Sector ETF
IGV
$14.1B
$1.53M ﹤0.01%
30,690
-373,835
-92% -$21.2M
PARA
6035
Banzai International
PARA
$4.81M
$1.53M ﹤0.01%
15
+13
+650% +$1.29M
PSEC icon
6036
CALL
Prospect Capital
PSEC
$1.11B
$1.53M ﹤0.01%
247,200
+71,200
+40% +$532K
WOR icon
6037
CALL
Worthington Enterprises
WOR
$2.82B
$1.53M ﹤0.01%
65,204
+49,795
+323% +$1.52M
GHI icon
6038
CALL
Greystone Housing Impact Investors LP
GHI
$139M
$1.53M ﹤0.01%
91,092
+41,452
+84% +$759K
ELP
6039
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$1.53M ﹤0.01%
322,816
-867,174
-73% -$4.46M
TPH
6040
DELISTED
Tri Pointe Homes
TPH
$1.53M ﹤0.01%
101,359
+35,479
+54% +$626K
SUSL icon
6041
iShares ESG MSCI USA Leaders ETF
SUSL
$1.22B
$1.53M ﹤0.01%
+24,781
New +$1.71M
AGQ icon
6042
PUT
ProShares Ultra Silver
AGQ
$1.48B
$1.53M ﹤0.01%
73,600
-43,500
-37% -$940K
ARCT icon
6043
CALL
Arcturus Therapeutics
ARCT
$231M
$1.53M ﹤0.01%
103,100
+13,600
+15% +$228K
DDM icon
6044
CALL
ProShares Ultra Dow30
DDM
$577M
$1.53M ﹤0.01%
62,600
+10,000
+19% +$301K
IPOD
6045
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1.53M ﹤0.01%
152,600
-73,200
-32% -$730K
IPOD
6046
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$1.53M ﹤0.01%
152,671
-35,260
-19% -$352K
ROCK icon
6047
CALL
Gibraltar Industries
ROCK
$1.41B
$1.53M ﹤0.01%
37,300
+700
+2% +$29.9K
AGNT
6048
CALL
AGNT Inc
AGNT
$710M
$1.53M ﹤0.01%
136,100
+21,000
+18% +$293K
NWN icon
6049
Northwest Natural Holdings
NWN
$2.12B
$1.53M ﹤0.01%
35,166
+21,461
+157% +$1.09M
PTC icon
6050
PTC
PTC
$15.8B
$1.53M ﹤0.01%
14,590
-80,844
-85% -$9.22M

Similar funds

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.